• Laxmaiah Manchikanti, Vidyasagar Pampati, Nebojsa Nick Knezevic, Alan D Kaye, Salahadin Abdi, Mahendra R Sanapati, Alaa Abd-Elsayed, Radomir Kosanovic, Amol Soin, Douglas P Beall, Shalini Shah, and Joshua A Hirsch.
• Pain Management Centers of America, Paducah, KY & Evansville, IN.
• Spine. 2023 Jul 1; 48 (13): 950961950-961.

Study DesignA retrospective cohort study of utilization patterns and variables of epidural injections in the fee-for-service (FFS) Medicare population.ObjectivesTo update the utilization of epidural injections in managing chronic pain in the FFS Medicare population, from 2000 to 2020, and assess the impact of COVID-19.Summary Of Background DataThe analysis of the utilization of interventional techniques also showed an annual decrease of 2.5% per 100,000 FFS Medicare enrollees from 2009 to 2018, contrasting to an annual increase of 7.3% from 2000 to 2009. The impact of the COVID-19 pandemic has not been assessed.MethodsThis analysis was performed by utilizing master data from the Centers for Medicare and Medicaid Services, physician/supplier procedure summary from 2000 to 2020. The analysis was performed by the assessment of utilization patterns using guidance from Strengthening the Reporting of Observational Studies in Epidemiology.ResultsEpidural procedures declined at a rate of 19% per 100,000 Medicare enrollees in the FFS Medicare population in the United States from 2019 to 2020, with an annual decline of 3% from 2010 to 2019. From 2000 to 2010, there was an annual increase of 8.3%. This analysis showed a decline in all categories of epidural procedures from 2019 to 2020. The major impact of COVID-19, with closures taking effect from April 1, 2020, through December 31, 2020, will be steeper and rather dramatic compared with April 1 to December 31, 2019. However, monthly data from the Centers for Medicare and Medicaid Services is not available as of now. Overall declines from 2010 to 2019 showed a decrease for cervical and thoracic transforaminal injections with an annual decrease of 5.6%, followed by lumbar interlaminar and caudal epidural injections of 4.9%, followed by 1.8% for lumbar/sacral transforaminal epidurals, and 0.9% for cervical and thoracic interlaminar epidurals.ConclusionDeclining utilization of epidural injections in all categories was exacerbated to a decrease of 19% from 2019 to 2020, related, in part, to the COVID-19 pandemic. This followed declining patterns of epidural procedures of 3% overall annually from 2010 to 2019.Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.

17 keywords...

hide…